Clinico-hematological profile and coronary artery changes detected at initial echocardiography in children with Kawasaki disease: a 12 years single centered experience from a tertiary care referral center of Bangladesh

Authors

  • M. Asif Ali Department of Pediatrics, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, Bangladesh
  • Mujammel Haque Department of Pediatrics, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, Bangladesh
  • M. Ridwanul Islam Department of Pediatrics, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, Bangladesh
  • Manik K. Talukder Department of Pediatrics, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, Bangladesh

DOI:

https://doi.org/10.18203/2349-3291.ijcp20250393

Keywords:

Kawasaki disease, Complete KD, Incomplete KD, Coronary artery aneurysm

Abstract

Background: Kawasaki disease (KD) is the most common cause of acquired heart disease in childhood. Coronary artery abnormalities may occur in 15-25% of children with KD. Our study aimed to analyze the demographic, clinical, laboratory profile and initial echocardiographic changes of coronary arteries among KD patients admitted in a tertiary care center in Bangladesh.

Methods: This was a retrospective study of 66 children diagnosed with KD admitted in the Department of Paediatrics from July 2010 to March 2023 at Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh.

Results: We found that 51.5% patients had complete KD while 48.5% had incomplete KD. Clinical profile showed fever, extremity changes, oral mucosal changes, maculopapular rash, cervical lymphadenopathy and non-purulent conjunctivitis in 100%, 72.7%, 68.2%, 62.1%, 50% and 48.5% cases respectively. Echocardiography done at the time of diagnosis demonstrated coronary artery abnormalities among 48.5% cases. Overall, 15.2% cases had small aneurysms, 7.6% patients had medium aneurysms and 4.5% cases had large or giant aneurysms in our study. Majority of the patients had developed LCA abnormalities (42.4%) followed by RCA abnormalities in 21.2% cases and LCX abnormalities in 7.6% cases.

Conclusions: In this study, we observed a slightly higher frequency of the complete KD (51.5%) in comparison to incomplete KD patients. Fever was the most consistent clinical feature followed by extremity changes, oral mucosal changes, maculopapular rash, cervical lymphadenopathy and lastly non-purulent conjunctivitis. Initial echocardiography revealed 48.5% patients with KD had coronary artery abnormalities with a predilection towards left coronary artery.

Metrics

Metrics Loading ...

References

Uehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol. 2012;22(2):79-85. DOI: https://doi.org/10.2188/jea.JE20110131

Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Jpn J Allergy. 1967;16:178-222.

Singh S, Vignesh P, Burgner D. The epidemiology of Kawasaki disease: a global update. Arch Dis Childhood. 2015;100(11):1084-8. DOI: https://doi.org/10.1136/archdischild-2014-307536

Kim GB. Reality of Kawasaki disease epidemiology. Korean J Pediatr. 2019;62(8):292. DOI: https://doi.org/10.3345/kjp.2019.00157

Singh S, Bhattad S. Kawasaki disease incidence at Chandigarh, North India, during 2009–2014. Rheumatol Int. 2016;36:1391-7. DOI: https://doi.org/10.1007/s00296-016-3543-y

McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927-99. DOI: https://doi.org/10.1161/CIR.0000000000000484

Newburger JW, Takahashi M, Burns JC. Kawasaki disease. J Am Coll Cardiol. 2016;67(14):1738-49. DOI: https://doi.org/10.1016/j.jacc.2015.12.073

Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974;54(3):271-6. DOI: https://doi.org/10.1542/peds.54.3.271

Burns JC. Kawasaki disease update. Indian J Pediatr. 2009;76(1):71-6. DOI: https://doi.org/10.1007/s12098-009-0031-3

Sharma D, Singh S. Kawasaki disease-A common childhood vasculitis. Indian J Rheumatol. 2015;10:S78-83. DOI: https://doi.org/10.1016/j.injr.2015.07.010

Wang Q, Morikawa Y, Akahoshi S, Miyata K, Sakakibara H, Matsushima T, et al. Follow-up duration of echocardiography in patients with kawasaki disease with no initial coronary aneurysms. J Pediatr. 2022;244:133-8. DOI: https://doi.org/10.1016/j.jpeds.2021.11.022

Bhattad S, Gupta S, Israni N, Mohanty S. Profile of Kawasaki disease at a tertiary care center in India. Ann Pediatr Cardiol. 2021;14(2):187-91. DOI: https://doi.org/10.4103/apc.APC_57_20

Jindal AK, Pilania RK, Guleria S, Vignesh P, Suri D, Gupta A, et al. Kawasaki disease in children older than 10 years: a clinical experience from Northwest India. Front Pediatr. 2020;8:24. DOI: https://doi.org/10.3389/fped.2020.00024

Tanaka A, Inoue M, Hoshina T, Koga H. Correlation of coronary artery abnormalities with fever pattern in patients with Kawasaki disease. J Pediatr. 2021;236:95-100. DOI: https://doi.org/10.1016/j.jpeds.2021.05.020

Ha KS, Jang GY, Lee J, Lee KC, Son CS. Laboratory markers in incomplete Kawasaki disease according to coronary artery outcome. Korean Circ J. 2018;48(4):287. DOI: https://doi.org/10.4070/kcj.2017.0342

Singh S, Gupta D, Suri D, Kumar RM, Ahluwalia J, Das R, et al. Thrombocytopenia as a presenting feature of Kawasaki disease: a case series from North India. Rheumatol Int. 2009;30:245-8. DOI: https://doi.org/10.1007/s00296-009-0947-y

Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet. 1984;2(8411):1055-8. DOI: https://doi.org/10.1016/S0140-6736(84)91504-6

Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986;315(6):341-7. DOI: https://doi.org/10.1056/NEJM198608073150601

Zhang T, Yanagawa H, Oki I, Nakamura Y, Yashiro M, Ojima T, et al. Factors related to cardiac sequelae of Kawasaki disease. Eur J Pediatr. 1999;158:694-7. DOI: https://doi.org/10.1007/s004310051181

Van Stijn D, Korbee JM, Netea SA, de Winter VC, Zwinderman KA, Kuipers IM, et al. Treatment and coronary artery aneurysm formation in Kawasaki Disease: a per-day risk analysis. J Pediatr. 2022;243:167-72. DOI: https://doi.org/10.1016/j.jpeds.2021.12.054

Fischer TK, Holman RC, Yorita KL, Belay ED, Melbye M, Koch A. Kawasaki syndrome in Denmark. Pediatr Infect Dis J. 2007;26(5):411-5. DOI: https://doi.org/10.1097/01.inf.0000259964.47941.00

Miah M, Hoque KZ, Islam MA, Sultana AT, Paul SP, Alam MJ. Clinical Profile of Kawasaki Disease (KD) in Children admitted at Dhaka Shishu Hospital. NIMCJ. 2017;14:216. DOI: https://doi.org/10.3329/nimcj.v8i2.32553

Begum NN, Mia AA, Mostafi M, Akhter K, Sultana M, Sarker FR. Kawasaki disease hospitalization: Outcomes in two tertiary care hospitals in Bangladesh. Bangl Med Res Council Bull. 2017;43(3):143-8. DOI: https://doi.org/10.3329/bmrcb.v43i3.36419

Sharma D, Iqbal F, Narayan Dev C, Bora S, Hoque RA, Kom LB. Clinical profile, treatment and outcome of Kawasaki disease: A single‐center experience from a tertiary care referral center of Assam, north‐east India. Int J Rheumat Dis. 2021;24(3):391-6. DOI: https://doi.org/10.1111/1756-185X.14059

Sakina S, Owais SS, Khan EA, Sheikh AM. Kawasaki disease: Clinico-laboratory spectrum and outcome in a cohort of children treated at a tertiary care hospital in Islamabad, Pakistan. Pak J Med Sci. 2020;36(2):260. DOI: https://doi.org/10.12669/pjms.36.2.910

Chiang CY, Ho CH, Chu CC, Chen ZC, Wang JJ, Tseng YZ. Coronary artery complications in pediatric patients with Kawasaki disease: a 12-year national survey. Acta Cardiologica Sinica. 2013;29(4):357.

Banoo N, Bashir A, Tariq S, Radhakrishnan S, Abid S. Clinical profile of Kawasaki disease in children admitted at a tertiary care hospital of North India and their short-term follow-up. Ann Pediatr Card. 2021;14:459-64. DOI: https://doi.org/10.4103/apc.APC_201_20

Kuo HC. Diagnosis, progress, and treatment update of Kawasaki disease. Int J Mol Sci. 2023;24(18):13948. DOI: https://doi.org/10.3390/ijms241813948

Singh S, Bansal A, Gupta A, Kumar RM, BR M. Kawasaki Disease A Decade of Experience From North India. Int Heart J. 2005;46(4):679-89. DOI: https://doi.org/10.1536/ihj.46.679

Wang W, Gong F, Zhu W, Fu S, Zhang Q. Macrophage activation syndrome in Kawasaki disease: more common than we thought? Semin Arthritis Rheumatism. 2015;44(4):405-10. DOI: https://doi.org/10.1016/j.semarthrit.2014.07.007

Suresh N, Sankar J. Macrophage activation syndrome: a rare complication of incomplete Kawasaki disease. Ann Trop Paediatr. 2010;30(1):61-4. DOI: https://doi.org/10.1179/146532810X12637745452239

Cameron SA, Carr M, Pahl E, DeMarais N, Shulman ST, Rowley AH. Coronary artery aneurysms are more severe in infants than in older children with Kawasaki disease. Arch Dis Childhood. 2019;104(5):451-5. DOI: https://doi.org/10.1136/archdischild-2018-314967

Downloads

Published

2025-02-24

How to Cite

Ali, M. A., Haque, M., Islam, M. R., & Talukder, M. K. (2025). Clinico-hematological profile and coronary artery changes detected at initial echocardiography in children with Kawasaki disease: a 12 years single centered experience from a tertiary care referral center of Bangladesh. International Journal of Contemporary Pediatrics, 12(3), 343–349. https://doi.org/10.18203/2349-3291.ijcp20250393

Issue

Section

Original Research Articles